43602e74-f078-4752-9f28-d52e0225ceb2-CN

Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures Next Generation Therapeutics for Infectious Diseases

Status
open for submission
Deadline
2 Sep 2026, 16:00 UTC
Estimated value
€252,000,000
Published
2 Jul 2026
Submission
Electronic submission
Tender summary

This call for tenders aims at speeding up the development of promising Next Generation Therapeutics for Infectious Diseases by adopting a competitive development in phases, under Pre-Commercial Procurement (PCP). The current deadline is 2 Sep 2026, 16:00 UTC. The listed estimated value is €252,000,000.

What the buyer needs

  • This call for tenders aims at speeding up the development of promising Next Generation Therapeutics for Infectious Diseases by adopting a competitive development in phases, under Pre-Commercial Procurement (PCP).
  • The scope of the call is expected to cover the development of innovative therapeutics to treat viral infections, ARDS or sepsis resulting from infections, including pathogen-targeted therapeutics (but not small molecules…
  • It may also cover innovative combinations therapies and products designed to be administered through alternative routes to IV.
  • Broad spectrum therapeutics, pathogen-agnostic therapeutics and therapeutics that could reduce or counteract the emergence of viral resistance are of particular interest.

Procurement signals

  • Procedure: HADEA/2026/CPN/0015
  • Procedure type: Source procedure code 47396208
  • Contract type: Services contract (31095498)
  • Submission method: Electronic submission
  • Published: 2 Jul 2026

Procurement categories

CPV 73100000 CPV 73000000

CPV labels are not yet mapped locally, so the official category codes are shown as source-backed identifiers.

Programme and geography

Programme period 2014 - 2020Programme period 2021 - 2027

Derived from official EU Funding & Tenders portal source fields. Use this as a shortlisting aid; the official tender record remains authoritative.

Source-backed details

Original identifiers and classification fields from the EU tender source.

Procedure identifier
HADEA/2026/CPN/0015
Business identifier
43602e74-f078-4752-9f28-d52e0225ceb2-CN
Procedure type
Source procedure code 47396208
Contract type
Services contract (31095498)
Authority source ID
47352360
Tender timezone
Europe/Brussels
Fetched
15 Jul 2026, 07:21 UTC
Full official description

This call for tenders aims at speeding up the development of promising Next Generation Therapeutics for Infectious Diseases by adopting a competitive development in phases, under Pre-Commercial Procurement (PCP). The scope of the call is expected to cover the development of innovative therapeutics to treat viral infections, ARDS or sepsis resulting from infections, including pathogen-targeted therapeutics (but not small molecules or monoclonal antibodies) and host-targeted therapeutics, among which but not only direct-acting antivirals, indirect-acting antivirals and novel immune modulators. It may also cover innovative combinations therapies and products designed to be administered through alternative routes to IV. Broad spectrum therapeutics, pathogen-agnostic therapeutics and therapeutics that could reduce or counteract the emergence of viral resistance are of particular interest.